Anli Jin
Impact in
- Physiology top 5%
- Adenosine and Purinergic Signaling
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 2
- Wnt/β-catenin signaling in development and cancer 2
- Extracellular vesicles in disease 2
- Oncology 4
- Cancer-related Molecular Pathways 2
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- Beili Wang (16 shared papers)Xin‐Rong Yang (9 shared papers)Hao Wang (10 shared papers)Wenjing Yang (7 shared papers)Jia Fan (6 shared papers)Baishen Pan (9 shared papers)Jian Zhou (3 shared papers)Yun‐Fan Sun (4 shared papers)
In The Last Decade
Anli Jin
15 papers receiving 399 citations
Peers
Comparison fields: 5 of 59
- Physiology 88
- Cancer Research 91
- Immunology 70
- Oncology 66
- Molecular Biology 178
Countries citing papers authored by Anli Jin
This map shows the geographic impact of Anli Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anli Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anli Jin more than expected).
Fields of papers citing papers by Anli Jin
This network shows the impact of papers produced by Anli Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anli Jin. The network helps show where Anli Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Anli Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 196 | |
| 2 | 2021 | 41 | |
| 3 | 2022 | 31 | |
| 4 | 2022 | 29 | |
| 5 | 1998 | 18 | |
| 6 | 2019 | 17 | |
| 7 | 2020 | 15 | |
| 8 | 2022 | 13 | |
| 9 | 2022 | 12 | |
| 10 | 2022 | 11 | |
| 11 | 2022 | 6 | |
| 12 | 2022 | 5 | |
| 13 | 2025 | 3 | |
| 14 | 2024 | 2 | |
| 15 | 2022 | 1 | |
| 16 | 2025 | 0 | |
| 17 | 2025 | 0 |
About Anli Jin
Anli Jin is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 17 papers that have together received 400 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Ferroptosis and cancer prognosis (2 papers), Circular RNAs in diseases (2 papers), Cancer-related Molecular Pathways (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Immune cells in cancer (2 papers), Extracellular vesicles in disease (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Physiology (88 citations), Cancer Research (91 citations), Immunology (70 citations), Oncology (66 citations) and Molecular Biology (178 citations). Anli Jin has collaborated with scholars based in China, Ethiopia and India. Frequent co-authors include Beili Wang, Xin‐Rong Yang, Hao Wang, Wenjing Yang, Jia Fan, Baishen Pan, Jian Zhou, Yun‐Fan Sun, Bo Hu and Wei Guo. Their work appears in journals such as Biomarkers in Medicine, Journal of Clinical Laboratory Analysis, Journal of Hematology & Oncology, BMC Gastroenterology and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.